- Home
- Pathology Industry
- Diagnostic Test Market and Forecasts, May 2012
Industries
- Pathology (89)
- In Vitro Diagnostic (68)
- Managed Care (42)
- Business Services (41)
- Diagnostics (40)
-
- Medical Facility (35)
- Drug and Medication (34)
- Healthcare (30)
- Genomics (22)
- Drug Discovery and Development (18)
- Education and Training (15)
- Health Insurance (14)
- Energy & Environment (12)
- Biotechnology (11)
- Oil and Gas Energy (11)
- Veterinary Healthcare (11)
- Tourism and Leisure (7)
- Blood Supply, Tissue Banking and Transplantation (6)
- E-healthcare (6)
- General Medicine and Specialty Medicine (6)
Top countries
Publication dates
All regions
-
- Australia (44)
- Belgium (2)
- Canada (56)
- Chile (1)
- Czech Republic (2)
- Denmark (1)
- Finland (6)
- France (5)
- Germany (12)
- Greece (11)
- Iceland (2)
- Ireland (11)
- Israel (2)
- Italy (7)
- Japan (7)
- Luxembourg (3)
- Mexico (1)
- Netherlands (10)
- New Zealand (15)
- Norway (3)
- Poland (2)
- Portugal (2)
- South Korea (4)
- Spain (4)
- Switzerland (7)
- Turkey (3)
- United Kingdom (20)
- United States (337)
Diagnostic Test Market and Forecasts, May 2012
You might be interested in: molecular diagnostic, diagnostics, clinical trial, more »
industry reports
country reports
Company Report: Diagnostics in Canada for Year 2012
- Company report
- March 2012
- 2 pages
... President and ceo of rna diagnostics inc. "This funding will support the ongoing development of rda a groundbreaking diagnostic test that will improve patient outcomes and reduce breast cancer treatment ...
- Industries: Diagnostics
- Countries: Canada
Investor presentation: Diagnostics for Year 2011
- Company report
- March 2011
- 32 pages
... As technological platform for novel diagnostic products based on mirna expression in serum. Exiqon has a proprietary pipeline of novel molecular diagnostic tests based on mirna profiling addressing large unmet ...
- Industries: Diagnostics
Company Report: Diagnostics for Year 2011
- Company report
- March 2011
- 4 pages
- by Corporation
... Molecular diagnostic testing systems that detect and measure dna and rna targets to diagnose disease and optimize patient treatment. Utilizing genmark's proprietary esensor detection technology, gen ...
- Industries: Diagnostics
Company Report: Diagnostics in The United States for Year 2011
- Company report
- October 2011
- 5 pages
... In cambridge, ma, wilex markets a portfolio of research use only and in vitro diagnostic tests under the brand oncogene science. These diagnostic tests could be developed as companion diagnostics in clinical ...
- Industries: Diagnostics
- Countries: United States
Investor presentation: Diagnostics in The United States for Year 2011
- Company report
- March 2011
- 20 pages
... For therapy assessment how patients will respond to a specific medical treatment monitoring of patient S treatment and outcome fda-registered in vitro diagnostic tests for patient use her2/neu elisa* and ca ...
- Industries: Diagnostics
- Countries: United States
Company Report: Diagnostics in The United States and Switzerland for Year 2011
- Company report
- August 2011
- 2 pages
... Of seegene S innovative molecular diagnostic tests. Covidien (+2.7%) And thoratec (+1.7%) Also delivered a positive performance while synthes (+1.3%) And axis-shield (+0.2%) Continued to trade higher ...
- Industries: Diagnostics
- Countries: United States, Switzerland
Company Report: In Vitro Diagnostic for Year 2011
- Company report
- December 2011
- 2 pages
- by Corporation
... Is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure dna and rna targets to diagnose disease and optimize patient treatment. Utilizing genmark's proprietary ...
- Industries: In Vitro Diagnostic
Osmetech Molecular Diagnostics - Company Report for Year 2011
- Company report
- December 2011
- 333 pages
... Or design, including diagnostic tests for genotyping the hepatitis c virus, and for mutations in a gene known as kras, which is predictive of an individual S response rates to certain prescribed anti ...
- Industries: In Vitro Diagnostic
- Countries: United States
Myriad Genetics Inc. - Annual Report 2011
- Company report
- September 2011
- 32 pages
- by Corporation
... Substantially all of our resources to supporting our molecular diagnostic tests and companion diagnostic services, as well as to the research and development of future molecular and companion diagnostic ...
- Industries: In Vitro Diagnostic
- Countries: United States
Wholesale Only - Company Report for Year 2011
- Company report
- December 2011
- 2 pages
... Davis S drug guide* taber S medical dictionary, 21 st edition diseases and disorders, 4 th edition davis S laboratory and diagnostic tests ...
- Industries: Book and Music Stores
- Countries: United States
Reportlinker.com © Copyright 2012. All rights reserved
